JPRN-UMIN000014354已完成未知
Examination of the medication effect using duloxetine in the patients with burning mouth syndrome and glossodynia - Examination of the medication effect using duloxetine in the patients with burning mouth syndrome and glossodynia
Depertment of Dental Anesthesiology, Division of Clinical Mediccal Sience, Programs for Applide Biomedicine, Graduate School of Biomedical Scinencice, Hiroshima University0 个研究点目标入组 30 人开始时间: 2014年6月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients with grave disease
研究者
相似试验
招募中
2 期
Phase II study of efficacy and safety of duloxetine for chlonic oxaliplatin-induced peripheral neuropathy in metastatic colorectal canceradvanced colorectal cancerJPRN-UMIN000010621Osaka City General Hospital Department of Clinical Oncology20
进行中（未招募）
不适用
A double-blind, efficacy and safety study of duloxetine versus placebo in the treatment of children and adolescents with major depressive disorderEUCTR2008-006492-71-DEEli Lilly and Company336
进行中（未招募）
1 期
A double-blind, efficacy and safety study of duloxetine versus placebo in the treatment of children and adolescents with major depressive disorderMajor depressive disorderMedDRA version: 9.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSEUCTR2008-006492-71-FREli Lilly and Company336
进行中（未招募）
不适用
A double-blind, efficacy and safety study of duloxetine versus placebo in the treatment of children and adolescents with major depressive disorderMajor depressive disorderMedDRA version: 9.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSEUCTR2008-006492-71-EEEli Lilly and Company336
进行中（未招募）
不适用
A double-blind, efficacy and safety study of duloxetine versus placebo in the treatment of children and adolescents with major depressive disorderMajor depressive disorderMedDRA version: 9.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSEUCTR2008-006492-71-FIEli Lilly and Company336